Annual Total Expenses
$295.22 M
-$17.36 M-5.55%
31 December 2023
Summary:
Sangamo Therapeutics annual total expenses is currently $295.22 million, with the most recent change of -$17.36 million (-5.55%) on 31 December 2023. During the last 3 years, it has risen by +$47.48 million (+19.16%). SGMO annual total expenses is now -5.55% below its all-time high of $312.58 million, reached on 31 December 2022.SGMO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$38.78 M
+$2.51 M+6.93%
30 September 2024
Summary:
Sangamo Therapeutics quarterly total expenses is currently $38.78 million, with the most recent change of +$2.51 million (+6.93%) on 30 September 2024. Over the past year, it has dropped by -$32.23 million (-45.38%). SGMO quarterly total expenses is now -53.06% below its all-time high of $82.62 million, reached on 31 December 2022.SGMO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.5% | -45.4% |
| 3 y3 years | +19.2% | -49.6% |
| 5 y5 years | +82.7% | -24.3% |
SGMO Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.5% | +19.2% | -53.1% | +6.9% |
| 5 y | 5 years | -5.5% | +82.7% | -53.1% | +6.9% |
| alltime | all time | -5.5% | >+9999.0% | -53.1% | +1287.8% |
Sangamo Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $38.78 M(+6.9%) |
| June 2024 | - | $36.27 M(-23.9%) |
| Mar 2024 | - | $47.66 M(-25.3%) |
| Dec 2023 | $295.22 M(-5.6%) | $63.80 M(-10.1%) |
| Sept 2023 | - | $71.01 M(-10.2%) |
| June 2023 | - | $79.06 M(-2.8%) |
| Mar 2023 | - | $81.35 M(-1.5%) |
| Dec 2022 | $312.58 M(+6.3%) | $82.62 M(+1.6%) |
| Sept 2022 | - | $81.35 M(+8.3%) |
| June 2022 | - | $75.11 M(+2.2%) |
| Mar 2022 | - | $73.49 M(+8.3%) |
| Dec 2021 | $294.04 M(+18.7%) | $67.89 M(-11.8%) |
| Sept 2021 | - | $77.00 M(+0.6%) |
| June 2021 | - | $76.57 M(+5.5%) |
| Mar 2021 | - | $72.58 M(+4.8%) |
| Dec 2020 | $247.74 M(+19.3%) | $69.23 M(+12.6%) |
| Sept 2020 | - | $61.46 M(+3.4%) |
| June 2020 | - | $59.45 M(+3.2%) |
| Mar 2020 | - | $57.60 M(+7.9%) |
| Dec 2019 | $207.61 M(+28.5%) | $53.38 M(+4.2%) |
| Sept 2019 | - | $51.21 M(+0.3%) |
| June 2019 | - | $51.05 M(-1.8%) |
| Mar 2019 | - | $51.97 M(+9.2%) |
| Dec 2018 | $161.60 M(+73.9%) | $47.61 M(+19.6%) |
| Sept 2018 | - | $39.80 M(-1.9%) |
| June 2018 | - | $40.56 M(+20.6%) |
| Mar 2018 | - | $33.63 M(+25.3%) |
| Dec 2017 | $92.93 M(+1.1%) | $26.84 M(+8.0%) |
| Sept 2017 | - | $24.85 M(+18.2%) |
| June 2017 | - | $21.02 M(+4.0%) |
| Mar 2017 | - | $20.22 M(+7.8%) |
| Dec 2016 | $91.95 M(+6.4%) | $18.75 M(-14.9%) |
| Sept 2016 | - | $22.03 M(-27.9%) |
| June 2016 | - | $30.54 M(+48.1%) |
| Mar 2016 | - | $20.62 M(-16.8%) |
| Dec 2015 | $86.39 M(+18.9%) | $24.79 M(+16.7%) |
| Sept 2015 | - | $21.25 M(+3.0%) |
| June 2015 | - | $20.64 M(+4.7%) |
| Mar 2015 | - | $19.71 M(+1.5%) |
| Dec 2014 | $72.65 M(+42.9%) | $19.42 M(-3.2%) |
| Sept 2014 | - | $20.07 M(+15.1%) |
| June 2014 | - | $17.43 M(+10.8%) |
| Mar 2014 | - | $15.73 M(+4.5%) |
| Dec 2013 | $50.84 M(+15.9%) | $15.04 M(+26.8%) |
| Sept 2013 | - | $11.87 M(-4.3%) |
| June 2013 | - | $12.40 M(+7.6%) |
| Mar 2013 | - | $11.53 M(-6.3%) |
| Dec 2012 | $43.85 M(-5.0%) | $12.30 M(+14.9%) |
| Sept 2012 | - | $10.71 M(+3.8%) |
| June 2012 | - | $10.32 M(-2.0%) |
| Mar 2012 | - | $10.53 M(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $46.14 M(+0.9%) | $11.11 M(-2.8%) |
| Sept 2011 | - | $11.43 M(-3.1%) |
| June 2011 | - | $11.79 M(-0.1%) |
| Mar 2011 | - | $11.80 M(-9.4%) |
| Dec 2010 | $45.74 M(+10.0%) | $13.03 M(+11.7%) |
| Sept 2010 | - | $11.66 M(+12.1%) |
| June 2010 | - | $10.40 M(-2.3%) |
| Mar 2010 | - | $10.65 M(-15.8%) |
| Dec 2009 | $41.59 M(+0.1%) | $12.66 M(+42.7%) |
| Sept 2009 | - | $8.87 M(-10.3%) |
| June 2009 | - | $9.88 M(-2.9%) |
| Mar 2009 | - | $10.18 M(+12.7%) |
| Dec 2008 | $41.56 M(+22.7%) | $9.03 M(-10.8%) |
| Sept 2008 | - | $10.13 M(-6.5%) |
| June 2008 | - | $10.83 M(-6.4%) |
| Mar 2008 | - | $11.57 M(+11.6%) |
| Dec 2007 | $33.87 M(+18.4%) | $10.37 M(+35.7%) |
| Sept 2007 | - | $7.64 M(-9.2%) |
| June 2007 | - | $8.42 M(+13.4%) |
| Mar 2007 | - | $7.43 M(-38.1%) |
| Dec 2006 | $28.61 M(+76.3%) | $12.00 M(+121.3%) |
| Sept 2006 | - | $5.42 M(-7.3%) |
| June 2006 | - | $5.85 M(+9.4%) |
| Mar 2006 | - | $5.34 M(+23.8%) |
| Dec 2005 | $16.23 M(+1.7%) | $4.32 M(+2.7%) |
| Sept 2005 | - | $4.20 M(+8.5%) |
| June 2005 | - | $3.87 M(+1.0%) |
| Mar 2005 | - | $3.84 M(+6.6%) |
| Dec 2004 | $15.96 M(+11.3%) | $3.60 M(-25.7%) |
| Sept 2004 | - | $4.85 M(-248.5%) |
| June 2004 | - | -$3.27 M(-181.8%) |
| Mar 2004 | - | $3.99 M(+31.6%) |
| Dec 2003 | $14.35 M(-59.6%) | $3.03 M(-12.7%) |
| Sept 2003 | - | $3.47 M(-17.7%) |
| June 2003 | - | $4.22 M(+16.5%) |
| Mar 2003 | - | $3.62 M(+3.5%) |
| Dec 2002 | $35.54 M(+75.4%) | $3.50 M(-84.4%) |
| Sept 2002 | - | $22.43 M(+416.5%) |
| June 2002 | - | $4.34 M(-17.5%) |
| Mar 2002 | - | $5.26 M(-14.3%) |
| Dec 2001 | $20.26 M(+27.3%) | $6.14 M(+4.6%) |
| Sept 2001 | - | $5.87 M(+27.5%) |
| June 2001 | - | $4.60 M(+25.9%) |
| Mar 2001 | - | $3.66 M(-25.9%) |
| Dec 2000 | $15.92 M(+160.9%) | $4.93 M(+25.6%) |
| Sept 2000 | - | $3.93 M(+13.6%) |
| June 2000 | - | $3.46 M(-3.8%) |
| Mar 2000 | - | $3.60 M |
| Dec 1999 | $6.10 M(+11.0%) | - |
| Dec 1998 | $5.50 M(+120.1%) | - |
| Dec 1997 | $2.50 M(+162.8%) | - |
| Dec 1996 | $950.00 K | - |
FAQ
- What is Sangamo Therapeutics annual total expenses?
- What is the all time high annual total expenses for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual total expenses year-on-year change?
- What is Sangamo Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly total expenses year-on-year change?
What is Sangamo Therapeutics annual total expenses?
The current annual total expenses of SGMO is $295.22 M
What is the all time high annual total expenses for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual total expenses is $312.58 M
What is Sangamo Therapeutics annual total expenses year-on-year change?
Over the past year, SGMO annual total expenses has changed by -$17.36 M (-5.55%)
What is Sangamo Therapeutics quarterly total expenses?
The current quarterly total expenses of SGMO is $38.78 M
What is the all time high quarterly total expenses for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly total expenses is $82.62 M
What is Sangamo Therapeutics quarterly total expenses year-on-year change?
Over the past year, SGMO quarterly total expenses has changed by -$32.23 M (-45.38%)